Genetic Polymorphisms of GSTM1 and Susceptibility to Bladder Cancer

Shao Jian
2006-01-01
Tumori
Abstract:Objective:To study the association between genetic polymorphisms of glutathione-S-transferases mu (GSTM)1 and susceptibility to bladder cancer. Methods:We obtained information on demographic factors,medical history,lifetime of tobacoo smoking and alcohol drinking, and occupational exposures by a personal interview. In a case control study,252 patients with primary bladder transitional carcinoma proved by pathological examination and 320 age- and sex-matched controls were included. The GSTM1 genotype was determined by PCR. Results:The frequency of GSTM1 null genotype was 45.2% in the bladder cancer patients and 30.9% in controls (OR=1.89,95%CI=1.28-4.40). The difference was significant (P0.05). In smokers, the frequency of GSTM1 null genotype was 66.2% in the bladder cancer patients and 27.3% in controls (OR=8.9;95%CI= 5.36-14.82). The difference was significant (P0.01). The risk of bladder cancer increased in subjects with the habit of compulsive urinary retention and the family history of cancer. Milk intake decreased the risk of bladder cancer. There was no statistical significance between the intake of fruit and the risk of bladder cancer. Conclusion:GSTM1 polymorphisms are associated with susceptibility to bladder cancer. It has the synergistic effects with smoking in the development of bladder cancer.
What problem does this paper attempt to address?